VENATORX PHARMACEUTICALS INC
Maintenance mode | Venatorx Pharmaceuticals
MALVERN, United States · Founded 2015 · $45.5M raised
- Headquarters
- MALVERN, Pennsylvania
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- venatorx.com
- Total Funding
- $45.5M
- Last Round
- $3.5M Series AApr 2022
- Rounds
- 3
About
VenatoRx Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel anti-infectives to combat multi-drug-resistant bacterial infections. Their lead program, cefepime-taniborbactam, is a beta-lactam/beta-lactamase inhibitor combination targeting carbapenem-resistant pathogens causing urinary tract infections and hospital-acquired pneumonia. The company has filed over 100 patents and received multiple BARDA contracts.
Summary
VENATORX PHARMACEUTICALS INC is a Biotech company based in MALVERN, United States, founded in 2015. It has raised $45.5M in total across 3 rounds, most recently a $3.5M Series A round in Apr 2022. Investors include AMR Action Fund and Abingworth.
Tech & App Stack
4 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Apr 2022
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...